Hui Fu

1.5k total citations
66 papers, 1.2k citations indexed

About

Hui Fu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Hui Fu has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Hui Fu's work include Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Hui Fu is often cited by papers focused on Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Hui Fu collaborates with scholars based in China, United States and Canada. Hui Fu's co-authors include Ning Zhang, Hua Guo, Meizhu Zheng, Jing Zhao, Fen Chang, Jinlan Wang, Gang Zheng, Yongqing Li, Deling Yin and Shangli Zhang and has published in prestigious journals such as Nature Communications, Diabetes and Scientific Reports.

In The Last Decade

Hui Fu

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Fu China 18 629 224 168 126 116 66 1.2k
Elif Damla Arısan Türkiye 23 756 1.2× 332 1.5× 229 1.4× 164 1.3× 75 0.6× 91 1.4k
Xuguang Zhang China 20 639 1.0× 208 0.9× 167 1.0× 186 1.5× 96 0.8× 78 1.4k
Lijun Zhang China 22 722 1.1× 178 0.8× 194 1.2× 150 1.2× 129 1.1× 63 1.4k
Zhipeng Wang China 21 765 1.2× 249 1.1× 330 2.0× 107 0.8× 155 1.3× 103 1.5k
Kui Zhao China 26 773 1.2× 158 0.7× 204 1.2× 123 1.0× 99 0.9× 65 1.8k
Anand Krishnan V. Iyer United States 25 824 1.3× 257 1.1× 207 1.2× 95 0.8× 127 1.1× 50 1.5k
Ganggang Shi China 25 763 1.2× 208 0.9× 146 0.9× 138 1.1× 190 1.6× 96 1.7k
Jiumao Lin China 22 703 1.1× 214 1.0× 247 1.5× 106 0.8× 111 1.0× 87 1.5k
Guobing� Li China 23 805 1.3× 205 0.9× 121 0.7× 220 1.7× 88 0.8× 47 1.4k
Yu Tian China 20 674 1.1× 241 1.1× 200 1.2× 178 1.4× 204 1.8× 60 1.4k

Countries citing papers authored by Hui Fu

Since Specialization
Citations

This map shows the geographic impact of Hui Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Fu more than expected).

Fields of papers citing papers by Hui Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Fu. The network helps show where Hui Fu may publish in the future.

Co-authorship network of co-authors of Hui Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Fu. A scholar is included among the top collaborators of Hui Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Fu. Hui Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaojuan, et al.. (2025). C-reactive protein to platelet ratio as an early biomarker in differentiating neonatal late-onset sepsis in neonates with pneumonia. Scientific Reports. 15(1). 10760–10760. 1 indexed citations
2.
3.
Fu, Hui, Zhentao Du, Louis Tong, et al.. (2025). Cr3+-induced broadband near-infrared I combined with near-infrared II emission via rare earth co-doping in Cs2NaInCl6 for multifunctional detection. Journal of Materials Chemistry C. 13(28). 14648–14656.
4.
5.
Li, Hongkun, Jiawei Li, Yifan Zhang, et al.. (2024). The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway. Frontiers in Pharmacology. 15. 1401979–1401979. 3 indexed citations
6.
7.
Wu, Yuqi, Jiawei Li, Liang Liu, et al.. (2024). Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement. International Journal of Biological Macromolecules. 273(Pt 2). 133063–133063. 16 indexed citations
8.
Ni, Chenxu, Yu Zhao, Hong Qian, et al.. (2023). Long survival in a pancreatic carcinoma patient with multi-organ toxicities after sintilimab treatment: A case report. Frontiers in Pharmacology. 14. 1121122–1121122. 1 indexed citations
9.
Liu, Jingwen, et al.. (2023). β‐Cell glucokinase expression was increased in type 2 diabetes subjects with better glycemic control. Journal of Diabetes. 15(5). 409–418. 9 indexed citations
10.
11.
Liu, Fangyuan, Luyi Xu, Hui Fu, et al.. (2022). Design and preparation of highly active TiO2 photocatalysts by modulating their band structure. Journal of Colloid and Interface Science. 629(Pt B). 336–344. 38 indexed citations
12.
Fu, Hui, et al.. (2022). Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Frontiers in Molecular Biosciences. 9. 941653–941653. 8 indexed citations
13.
Li, Shanshan, Hui Fu, Yiyang Wang, et al.. (2020). Curcumin inhibits CT26 cells metastasis by decreasing heparanase expression. Journal of Leukocyte Biology. 108(6). 1727–1733. 7 indexed citations
14.
Yang, Yuhui, Xue Liu, Hui Fu, et al.. (2018). The development of salt-sensitive hypertension regulated by PSGL-1 gene in mice. Cell & Bioscience. 8(1). 20–20. 13 indexed citations
15.
Zhang, Xiaoyu, Shuwu Zhao, Xinbo Song, et al.. (2018). Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition. Journal of Pharmacological Sciences. 137(4). 324–332. 82 indexed citations
16.
Chen, Lu, Hui Fu, Yi Luo, et al.. (2017). cPLA2α mediates TGF-β-induced epithelial–mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death and Disease. 8(4). e2728–e2728. 53 indexed citations
17.
Liu, Jing, Hui Fu, Fen Chang, et al.. (2016). Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2/STAT3 signaling pathway. APOPTOSIS. 21(5). 546–557. 11 indexed citations
18.
Chang, Fen, Jing Liu, Hui Fu, et al.. (2016). GSK-3β promotes PA-induced apoptosis through changing β-arrestin 2 nucleus location in H9c2 cardiomyocytes. APOPTOSIS. 21(9). 1045–1055. 5 indexed citations
19.
20.
Zhu, Qi, Kai Xu, Hui Fu, et al.. (2008). EUS-guided oncolytic adenovirus implantation in patients of non-operative pancreatic cancer. Zhonghua xiaohua neijing zazhi. 25(7). 341–346. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elif Damla Arısan Breakdown of academic impact, for papers by Xuguang Zhang Breakdown of academic impact, for papers by Lijun Zhang Breakdown of academic impact, for papers by Zhipeng Wang Breakdown of academic impact, for papers by Kui Zhao Breakdown of academic impact, for papers by Anand Krishnan V. Iyer Breakdown of academic impact, for papers by Ganggang Shi Breakdown of academic impact, for papers by Jiumao Lin Breakdown of academic impact, for papers by Guobing� Li Breakdown of academic impact, for papers by Yu Tian
Rankless by CCL
2026